skin cancer
The AI, integrated into a hand-held point-of-care device, demonstrated 94% diagnostic accuracy. 
        
        
          Trained on two million skin images, it can perform a range of clinical tasks unlike current models.
        
        
          LifeSemantics plans to commercialise its mobile app-based AI screening solution by yearend.
        
        
          Developers see a potential use of the AI-powered mobile solution for routine early skin cancer screening.
        
        
          It seeks to raise the number of skin checks in Australia by a quarter.
        
        
          Also, study finds digital physiotherapy app is clinically effective.
        
        
          The Danish consumer platform helps users track skin changes.
        
        
           
 
 
 
 
 
